NCIMB, a leading microbiology services provider and owner of the UK’s largest industrial, food and marine bacterial culture collection, has secured a £1.7m investment from the Investment Fund for Scotland (IFS) – Maven Equity Finance and the Scottish National Investment Bank.
NCIMB provides microbial identification, testing and safe storage services and supplies bacterial stains from its globally recognised collection for commercial and academic use. The business services customers operating in a number of industries, including pharmaceuticals, biotechnology, food & drink, energy, and environmental sectors, from its state-of-the-art laboratory facility in Aberdeen.
The investment will be used to strengthen NCIMB’s business development and marketing functions to accelerate growth in its core microbiology and strain licensing services. It will also enable the business to broaden its service offering to include the selection and development of bacterial strains in its collection for specific customer applications.
PMSI provided CDD to support the transaction, including in-depth analysis of NCIMB’s competitive positioning, an assessment of NCIMB’s future growth strategies, as well as a full customer feedback exercise to demonstrate the business’s core value proposition moving forwards.
Article
Kester Capital acquires EMAS Pharma
Kester Capital (“Kester”), a leading UK private equity investor, today announced its acquisition, alongside an experienced incoming executive team, of EMAS P...